BEESFREE, Inc. BEES Company Overview Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2013 at 10:48 PM

BEESFREE, Inc. BEES Company Overview

Stock Message Board http://investorshangout.com/search?q=BEES&...mp;yt1=Go!

BEESFREE, Inc. BEES Current Price and Quotes
0.465
Previous Close
0.465
Open
N/A

Daily Range
N/A - N/A
52wk Range
1.91 - 0.055

Volume
0
Dividend
N/A

Average Vol (3m)
7,579
Yield
N/A

BEESFREE, Inc. BEES
Company Information
2101 Vista Parkway
Suite 122
West Palm Beach, FL 33411

Website: http://www.beesfree.biz
Phone: 561-939-4860

BEESFREE, Inc. BEES
BeesFree Inc. is a development stage company that develops and commercializes innovative solutions for the beekeeping community. We intend to operate on a global basis. We plan to manufacture and sell our patent-pending technology that dispenses and delivers our proprietary mixture of chemical compounds to the bee population in order to prevent the effects of colony collapse disorder or CCD. CCD is a phenomenon in which worker bees from beehive or colony abruptly disappear. Generally, a live qu...

BEESFREE, Inc. BEES
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001432139
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 5190 - Wholesale-Miscellaneous Nondurable Goods
Business Status Development Stage Company a/o Mar 01, 2012
Incorporated In: NV, USA
Year of Inc. 2011
Employees 3 a/o Mar 01, 2012
Company Officers/Contacts
Joseph Fasciglione Interim CEO, Interim CFO
Company Directors
Andrea Festucci
Company Notes
Formerly=BNH, Inc. until 10-2011
Service Providers
Auditor/Accountant
Marcum LLP
750 Third Ave
New York, NY, 10017
United States

Legal Counsel
Not Available
Investor Relations Firm
Alliance Advisors, LLC
420 Lexington Ave
New York, NY, 10170
United States

BEESFREE, Inc. BEES
BEES Security Details
Share Structure
Market Value1 $7,600,299 a/o Sep 03, 2013
Shares Outstanding 16,344,728 a/o Aug 09, 2013
Float 4,000,000 a/o Mar 14, 2012
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record 173 a/o Mar 29, 2013
Security Notes
Capital Change=shs increased by 2 for 1 split. Pay date=10/27/2011.
Short Selling Data
Short Interest 0 (-100%)
Apr 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)
VStock Transfer

BEESFREE, Inc. BEES Recent News

Aug 22, 2013 BeesFree Signs Second Manufacturing Agreement to Supply United States Market with BeesVita Plus
Jul 31, 2013 BeesFree Signs New Sales and Cooperation Agreement for the Distribution and Marketing of BeesVita(TM) Plus in Argentina
Jul 26, 2013 BeesFree Executive Team Meets with Top Officials in the State of Iowa as BeesVita Plus Product Launch Gains Momentum and Receives Attention from Accredited Investors in America's Heartland
Jul 24, 2013 BeesFree Signs Manufacturing Agreement in Argentina to Meet Substantial BeesFree Product Demand for All of South America

BEESFREE, Inc. BEES Financials
Period Ending Dec 31, 2012 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 213 - - -
Sales, General and Admin. 1,420 51 59 29
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,633) (51) (59) (29)
Income From Continuing Operations
Add'l Income/Expense Items (67) - - -
Earnings Before Interest and Tax (1,699) (51) (59) (29)
Interest Expense - - - -
Earnings Before Tax (1,699) (51) (59) (29)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,699) (51) (59) (29)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,699) (51) (59) (29)
Preferred Stock and Other Adjustments (191) - - -
Net Income Applicable to Common Shareholders (1,891) (51) (59) (29)

BEES BEESFREE, Inc. Research DD Guide

BEES BEESFREE, Inc. Stock Message Board http://investorshangout.com/search?q=BEES&...mp;yt0=Go!
BEES BEESFREE, Inc. Stock Quote http://www.otcmarkets.com/stock/BEES/quote
BEES BEESFREE, Inc. Stock Chart http://www.otcmarkets.com/stock/BEES/chart
BEES BEESFREE, Inc. Company Info http://www.otcmarkets.com/stock/BEES/company-info
BEES BEESFREE, Inc. Recent News http://www.otcmarkets.com/stock/BEES/news
BEES BEESFREE, Inc. Financials http://www.otcmarkets.com/stock/BEES/financials
BEES BEESFREE, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/BEES/filings
BEES BEESFREE, Inc. Short Sales http://www.otcmarkets.com/stock/BEES/short-sales
BEES BEESFREE, Inc. Insider Disclosure http://www.otcmarkets.com/stock/BEES/insider-transactions
BEES BEESFREE, Inc. Research Reports http://www.otcmarkets.com/stock/BEES/research
BEES BEESFREE, Inc. Summary http://finance.yahoo.com/q?s=BEES
BEES BEESFREE, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=BEES+Historical+Prices
BEES BEESFREE, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=BEES
BEES BEESFREE, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=BEES+Basic+Chart
BEES BEESFREE, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BEES+Basic+Tech.+Analysis
BEES BEESFREE, Inc. Headlines http://finance.yahoo.com/q/h?s=BEES+Headlines
BEES BEESFREE, Inc. Press Releases http://finance.yahoo.com/q/p?s=BEES+Press+Releases
BEES BEESFREE, Inc. Company Profile http://finance.yahoo.com/q/pr?s=BEES+Profile
BEES BEESFREE, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=BEES+Key+Statistics
BEES BEESFREE, Inc. Industry http://finance.yahoo.com/q/in?s=BEES+Industry
BEES BEESFREE, Inc. Major Holders http://finance.yahoo.com/q/mh?s=BEES+Major+Holders
BEES BEESFREE, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=BEES+Insider+Transactions
BEES BEESFREE, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=BEES+Insider+Roster
BEES BEESFREE, Inc. Income Statement http://finance.yahoo.com/q/is?s=BEES
BEES BEESFREE, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=BEES
BEES BEESFREE, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=BEES+Cash+Flow&annual
BEES BEESFREE, Inc. Nasdaq http://www.nasdaq.com/symbol/BEES
BEES BEESFREE, Inc. Market Watch http://www.marketwatch.com/investing/stock/BEES
BEES BEESFREE, Inc. Bloomberg http://www.bloomberg.com/quote/BEES:US
BEES BEESFREE, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=BEES
BEES BEESFREE, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=BEES
BEES BEESFREE, Inc. Barchart http://www.barchart.com/quotes/stocks/BEES
BEES BEESFREE, Inc. OTC Short Report http://otcshortreport.com/index.php?index=BEES
BEES BEESFREE, Inc. Investopedia http://www.investopedia.com/markets/stocks/BEES/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...